AIFA: pharmaceutical expenditure data still preliminary and hardly predictive

News Healthcare & Pharma Reports

Date: 3rd Oct, 2024 Source: Italian Medicines Agency (AIFA) Country: Italy Original Source

Brief

"On "03/10/2024", the "Italian Medicines Agency (AIFA)" issued an update regarding "AIFA: pharmaceutical expenditure data still preliminary and hardly predictive". The Director Tecnico-Scientifico, Pierluigi Russo, stated that the monitoring data for January-February 2024 are preliminary and not predictive of the final expenditure. The Agency is receiving corrections from some Regions on the data for March and April months.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

AIFA: pharmaceutical expenditure data still preliminary and hardly predictive

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

AIFA: pharmaceutical expenditure data still preliminary and hardly predictive

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.